AmerisourceBergen to pay $625M to settle whistleblower case for selling cancer vial overfills

AmerisourceBergen agreed on Monday to pay $625 million to resolve civil charges against the company that a former subsidiary repackaged millions of vials of cancer drugs to harvest and sell their overfills.